Replies to post #5993 on Radient Pharmaceuticals Corporation fka RXPC

[bikaver]

PR Newswire. Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation. Collaborative US Clinical Data Shows Highly Promising Results